T
Timo Erkinjuntti
Researcher at University of Helsinki
Publications - 311
Citations - 32430
Timo Erkinjuntti is an academic researcher from University of Helsinki. The author has contributed to research in topics: Dementia & Vascular dementia. The author has an hindex of 88, co-authored 310 publications receiving 30068 citations. Previous affiliations of Timo Erkinjuntti include Newcastle University & university of lille.
Papers
More filters
Journal ArticleDOI
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.
Bengt Winblad,Katie Palmer,Miia Kivipelto,Vesna Jelic,Laura Fratiglioni,Lars-Olof Wahlund,Agneta Nordberg,Lars Bäckman,Marilyn S. Albert,Ove Almkvist,Hiroyuki Arai,Hans Basun,Kaj Blennow,M. J. de Leon,Charles DeCarli,Timo Erkinjuntti,Ezio Giacobini,Caroline Graff,John Hardy,Clifford R. Jack,Anthony F. Jorm,Karen Ritchie,C M van Duijn,Pieter Jelle Visser,Ronald C. Petersen +24 more
TL;DR: A multidisciplinary, international group of experts discussed the current status and future directions of MCI, with regard to clinical presentation, cognitive and functional assessment, and the role of neuroimaging, biomarkers and genetics.
Journal ArticleDOI
A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT
L-O Wahlund,Frederik Barkhof,Franz Fazekas,Lena Bronge,M. Augustin,Magnus Sjögren,Anders Wallin,Herman J. Adèr,Didier Leys,Leonardo Pantoni,Florence Pasquier,Timo Erkinjuntti,Philip Scheltens +12 more
TL;DR: A new ARWMC scale applicable to both CT and MRI that has almost equal sensitivity, except for certain regions is presented, including frontal area and basal ganglia and infratentorial areas.
Book
Vascular Cognitive Impairment
John T. O'Brien,Timo Erkinjuntti,Barry Reisberg,Gustavo C. Román,Tohru Sawada,Leonardo Pantoni,John V. Bowler,Clive Ballard,Charles DeCarli,Philip B. Gorelick,Kenneth Rockwood,Alistair Burns,Serge Gauthier,Steven T. DeKosky +13 more
TL;DR: Findings from 5 large, randomized studies of the symptomatic treatment of probable and possible vascular dementia indicate that the presence of a cholinergic deficit is not required for the anticholinesterases to produce cognitive improvement, and so the cholin allergic hypothesis is neither necessary nor sufficient to explain the effects of these drugs.
Journal ArticleDOI
Subcortical ischaemic vascular dementia
TL;DR: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL)and some forms of cerebral amyloid angiopathy have a genetic basis.
Journal ArticleDOI
Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial
TL;DR: Galantamine showed a therapeutic effect on all key areas of cognitive and non-cognitive abilities in this group of dementia patients and was well tolerated.